Synplogen
Developer of a genetic engineering platform designed to perform deoxyribonucleic acid synthesis. The company's platform offers long-chain DNA synthesis support for creating production-use microbes and...
Valuation
$50.8M
Market implied
Share Price
N/A
Total Raised
$31.5M
Last Round
N/A